NAMSDL is a 501(c)(3) nonprofit organization dedicated to comprehensive, integrative and effective state drug laws, policies and programs
Highlighted Issues
designer drug
 

This document provides a summary of legislation and regulation introduced during calendar year 2017 that pertains to novel psychoactive substances (“NPS”) and controlled substance analogues. Read more »

analog analogue bill status update cannabinoid cathinone designer drug fentanyl new psychoactive substance novel psychoactive substance nps schedule synthetic drug

 

This document is a product of NAMSDL’s extensive review and analysis of current state laws addressing novel psychoactive substances (“NPS”) and controlled substance analogues. On a state-by-state basis, NAMSDL lays out laws pertaining to many issues, including: expeditious scheduling, definition/treatment of analogues, fentanyl-specific provisions and penalties for violations. Read more »

analog analogue cannabinoid cathinone designer drug fentanyl new psychoactive substance novel psychoactive substance nps schedule synthetic drug

1